Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 5.47%
March 31, 2026 6.26%
December 31, 2025 7.34%
September 30, 2025 7.29%
June 30, 2025 4.55%
March 31, 2025 6.00%
December 31, 2024 1.03%
September 30, 2024 2.68%
June 30, 2024 0.28%
March 31, 2024 3.19%
December 31, 2023 0.51%
September 30, 2023 -3.46%
June 30, 2023 4.51%
March 31, 2023 4.09%
December 31, 2022 2.95%
September 30, 2022 1.66%
June 30, 2022 2.93%
March 31, 2022 7.38%
December 31, 2021 7.50%
September 30, 2021 3.04%
June 30, 2021 7.77%
March 31, 2021 5.74%
December 31, 2020 6.21%
September 30, 2020 6.30%
June 30, 2020 3.01%
Date Value
March 31, 2020 6.41%
December 31, 2019 5.56%
September 30, 2019 1.33%
June 30, 2019 4.32%
March 31, 2019 7.22%
December 31, 2018 6.76%
September 30, 2018 8.15%
June 30, 2018 10.43%
March 31, 2018 9.50%
December 31, 2017 3.42%
September 30, 2017 8.22%
June 30, 2017 7.91%
March 31, 2017 12.45%
December 31, 2016 7.00%
September 30, 2016 6.48%
June 30, 2016 8.03%
March 31, 2016 10.13%
December 31, 2015 15.74%
September 30, 2015 10.02%
June 30, 2015 5.62%
March 31, 2015 8.90%
December 31, 2014 8.16%
September 30, 2014 10.93%
June 30, 2014 -9.60%
March 31, 2014 3.68%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 28.00%
ANI Pharmaceuticals, Inc. 8.65%
Corcept Therapeutics, Inc. 16.45%
Veru, Inc. --
Johnson & Johnson 21.86%